Page last updated: 2024-12-06

5-methylnicotinamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5-Methylnicotinamide (5MN) is a pyridine derivative and a metabolite of nicotinamide. It is formed through the methylation of nicotinamide by the enzyme nicotinamide N-methyltransferase. 5MN is a potent inhibitor of the enzyme poly(ADP-ribose) polymerase (PARP), which plays a role in DNA repair and cell death. 5MN has been shown to have various biological effects, including anti-inflammatory, anti-cancer, and neuroprotective properties. Research on 5MN focuses on its potential therapeutic applications, particularly in the treatment of cancer, neurodegenerative diseases, and inflammatory conditions. Studies have investigated 5MN's ability to modulate the immune system, reduce inflammation, and protect against DNA damage. 5MN is also being explored for its potential in regenerative medicine due to its role in promoting cell growth and differentiation.'

5-methylnicotinamide: potentiates cytotoxicity of N-methyl-N-nitrosourea [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID65560
CHEMBL ID4544263
SCHEMBL ID832732
MeSH IDM0083369

Synonyms (29)

Synonym
AC-17952
NCIOPEN2_001036
3-pyridinecarboxamide, 5-methyl-
70-57-5
nicotinamide, 5-methyl-
nsc87668
nsc-87668
5-methylpyridine-3-carboxamide
5-methylnicotinamide
A836923
5-methyl-3-pyridinecarboxamide
AKOS006223455
unii-54us8zug7j
nsc 87668
54us8zug7j ,
FT-0645440
SCHEMBL832732
BCCUXBGEPLKSEX-UHFFFAOYSA-N
DTXSID30220254
mfcd05664041
CS-0037467
3-pyridinecarboxamide,5-methyl-
5-methyl nicotinamide
EN300-101531
AS-57377
AB11819
SB53966
CHEMBL4544263
Z1203579033
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-199022 (91.67)18.7374
1990's2 (8.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.05

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.05 (24.57)
Research Supply Index3.22 (2.92)
Research Growth Index4.27 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.05)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (4.17%)4.05%
Observational0 (0.00%)0.25%
Other23 (95.83%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]